文献速递泌尿生殖介入MR

磁共振腔内经直肠前列腺穿刺活检:是否存在并发症的危险因素?

In-bore transrectal MRI-guided prostate biopsies: Are there risk factors for complications?
PubMed 文献 · Eur J Radiol · 2016-10-01

该研究纳入90例拟行磁共振腔内经直肠前列腺穿刺活检的患者,分析年龄、前列腺体积、穿刺针数、穿刺时长、多病灶活检、糖尿病、高血压、痔疮、良性前列腺增生、癌或前列腺炎及病灶位置等可能危险因素与并发症的关系,并按Clavien-Dindo分级记录并发症;结果显示15例(16.7%)为I级并发症,仅1例(1.1%)为II级并发症,无III级及以上并发症,所评估的危险因素与活检相关并发症均无显著关联。

要点

  • 磁共振腔内经直肠前列腺穿刺活检的并发症发生率低,本组I级并发症15/90例(16.7%),II级仅1/90例(1.1%)。
  • 轻微血尿9/90例(10%)、轻度血管迷走反应4/90例(4.4%)为最常见的I级并发症。
  • 所评估的危险因素与活检相关并发症均无显著关联,作者认为似乎不存在并发症危险因素。

核心结论

  • 磁共振腔内经直肠MRI引导前列腺穿刺活检可被认为是诊断前列腺癌的安全操作,并发症发生率极低,似乎不存在并发症的危险因素。

研究设计与样本

  • 研究纳入90例拟行磁共振腔内经直肠MRI引导前列腺穿刺活检的患者,排除凝血障碍、抗凝药物治疗及泌尿系统和下消化道急性感染者,于活检后即刻、1周和1年评估活检相关并发症。

诊断标准与关键数值

  • 并发症按Clavien-Dindo分级:I级15/90例(16.7%),包括轻微血尿9例(10%)、轻度血管迷走反应4例(4.4%)、尿潴留1例(1.1%)和体位相关面部感觉异常1例(1.1%);II级为需抗生素治疗的急性前列腺炎1例(1.1%);无III级及以上并发症。

临床应用与阅片要点

  • 作者认为磁共振腔内经直肠MRI引导前列腺穿刺活检可被视为诊断前列腺癌的安全操作,并发症发生率极低,且似乎不存在并发症的危险因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To systematically analyze risk factors for complications of in-bore transrectal MRI-guided prostate biopsies (MRGB).

MATERIALS AND METHODS: 90 patients, who were scheduled for MRGB were included for this study. Exclusion criteria were coagulation disorders, therapy with anticoagulant drugs, and acute infections of the urinary and the lower gastrointestinal tract. Directly after, one week and one year after the biopsy, we assessed biopsy related complications (e.g. hemorrhages or signs of prostatitis). Differences between patients with and without complications were analyzed regarding possible risk factors: age, prostate volume, number of taken samples, biopsy duration, biopsy of more than one lesion, diabetes, arterial hypertension, hemorrhoids, benign prostate hyperplasia, carcinoma or prostatitis (according to histopathological analysis), and lesion localization. Complications were classified according to the Clavien-Dindo classification.

RESULTS: We observed 15 grade I complications in 90 biopsies (16.7%) with slight hematuria in 9 cases (10%), minor vasovagal reactions in 4 cases (4.4%), and urinary retention and positioning-related facial dysesthesia in 1 case each (1.1%). One patient showed acute prostatitis requiring antibiotics as the only grade II complication (1.1%). There were no adverse events that occurred later than one week. Complications grade III or higher such as pelvic abscesses, urosepsis or severe hemorrhages were not seen. There were no significant associations between the assessed risk factors and biopsy-related complications.

CONCLUSION: In-bore transrectal MRI-guided prostate biopsies can be considered safe procedures in the diagnosis of prostate cancer with very low complication rates. There seem to be no risk factors for complications.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Meier-Schroers M, Homsi R, Kukuk G, et al. In-bore transrectal MRI-guided prostate biopsies: Are there risk factors for complications? Eur J Radiol. 2016. PMID: 27842662. doi:10.1016/j.ejrad.2016.09.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。